Literature DB >> 30472185

Hybrids by tumor-associated macrophages × glioblastoma cells entail nuclear reprogramming and glioblastoma invasion.

Mian-Fu Cao1, Lu Chen1, Wei-Qi Dang1, Xian-Chao Zhang1, Xiang Zhang1, Yu Shi1, Xiao-Hong Yao1, Qian Li1, Jiang Zhu1, Yong Lin1, Sha Liu1, Qian Chen1, Yong-Hong Cui1, Xia Zhang2, Xiu-Wu Bian3.   

Abstract

Hybrid formation is a fundamental process in normal development and tissue homeostasis, while the presence and the biological role of hybrids between tumor-associated macrophages (TAMs) and glioblastoma (GBM) cells remain elusive. In this study, we observed that TAM-GBM cell hybrids existed in human GBM specimens as demonstrated by co-expression of glioma biomarkers (GFAP, IDH1R132H and PDGFRA) and macrophage biomarkers (CD68 and CD14). Furthermore, TAM-GBM cell hybrids could also be found in C57BL/6 mice orthotopically inoculated with mouse GBM cells labeled with RFP and after co-culture of bone marrow-derived macrophages from GFP-expressed mice with RFP-labeled GBM cells. The hybrids underwent nuclear reprogramming with unique gene expression profile as compared to parental cells. Moreover, glioma invasion-associated genes were enriched in the hybrids that possessed higher invasiveness, and more hybrids in the invasive margin of GBM were observed as compared to GBM core area. Our data demonstrate the presence of TAM-GBM cell hybrids that enhance GBM invasion. With a better understanding of TAM-GBM cell hybrids, new therapeutic strategies targeting GBM will be developed to treat GBM patients.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Glioblastoma invasiveness; Tumor immunity; Tumor microenvironment

Mesh:

Year:  2018        PMID: 30472185     DOI: 10.1016/j.canlet.2018.11.016

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  10 in total

1.  Combination of p38 MAPK inhibitor with PD-L1 antibody effectively prolongs survivals of temozolomide-resistant glioma-bearing mice via reduction of infiltrating glioma-associated macrophages and PD-L1 expression on resident glioma-associated microglia.

Authors:  Weiqi Dang; Jingfang Xiao; Qinghua Ma; Jingya Miao; Mianfu Cao; Lu Chen; Yu Shi; Xiaohong Yao; Shichang Yu; Xindong Liu; Youhong Cui; Xia Zhang; Xiuwu Bian
Journal:  Brain Tumor Pathol       Date:  2021-07-06       Impact factor: 3.298

2.  Zyxin (ZYX) promotes invasion and acts as a biomarker for aggressive phenotypes of human glioblastoma multiforme.

Authors:  Xian-Mei Wen; Tao Luo; Yi Jiang; Li-Hong Wang; Ying Luo; Qian Chen; Kaidi Yang; Ye Yuan; Chunhua Luo; Xiang Zhang; Ze-Xuan Yan; Wen-Juan Fu; Yu-Huan Tan; Qin Niu; Jing-Fang Xiao; Lu Chen; Jiao Wang; Jia-Feng Huang; You-Hong Cui; Xia Zhang; Yan Wang; Xiu-Wu Bian
Journal:  Lab Invest       Date:  2020-01-16       Impact factor: 5.662

Review 3.  Never Travel Alone: The Crosstalk of Circulating Tumor Cells and the Blood Microenvironment.

Authors:  Simon Heeke; Baharia Mograbi; Catherine Alix-Panabières; Paul Hofman
Journal:  Cells       Date:  2019-07-13       Impact factor: 6.600

4.  Identification of CD101 in Glioma: A Novel Prognostic Indicator Expressed on M2 Macrophages.

Authors:  Yuyang Liu; Renqi Yao; Ying Shi; Yuxiao Liu; Hongyu Liu; Jialin Liu; Yunqian Guan; Yongming Yao; Ling Chen
Journal:  Front Immunol       Date:  2022-03-08       Impact factor: 7.561

Review 5.  Cancer Stem Cell-Associated Immune Microenvironment in Recurrent Glioblastomas.

Authors:  Yoshitaka Murota; Kouichi Tabu; Tetsuya Taga
Journal:  Cells       Date:  2022-06-28       Impact factor: 7.666

Review 6.  A narrative review of circulating tumor cells clusters: A key morphology of cancer cells in circulation promote hematogenous metastasis.

Authors:  Qiong Chen; Jueyao Zou; Yong He; Yanhong Pan; Gejun Yang; Han Zhao; Ying Huang; Yang Zhao; Aiyun Wang; Wenxing Chen; Yin Lu
Journal:  Front Oncol       Date:  2022-08-18       Impact factor: 5.738

Review 7.  Circulating Cells with Macrophage-like Characteristics in Cancer: The Importance of Circulating Neoplastic-Immune Hybrid Cells in Cancer.

Authors:  Thomas L Sutton; Ranish K Patel; Ashley N Anderson; Stephen G Bowden; Riley Whalen; Nicole R Giske; Melissa H Wong
Journal:  Cancers (Basel)       Date:  2022-08-11       Impact factor: 6.575

8.  The E3 ubiquitin ligase HUWE1 acts through the N-Myc-DLL1-NOTCH1 signaling axis to suppress glioblastoma progression.

Authors:  Ye Yuan; Li-Hong Wang; Xian-Xian Zhao; Jiao Wang; Meng-Si Zhang; Qing-Hua Ma; Sen Wei; Ze-Xuan Yan; Yue Cheng; Xiao-Qing Chen; Hong-Bo Zou; Jia Ge; Yan Wang; Xia Zhang; You-Hong Cui; Tao Luo; Xiu-Wu Bian
Journal:  Cancer Commun (Lond)       Date:  2022-07-18

Review 9.  Macrophages/Microglia in the Glioblastoma Tumor Microenvironment.

Authors:  Jun Ma; Clark C Chen; Ming Li
Journal:  Int J Mol Sci       Date:  2021-05-28       Impact factor: 5.923

Review 10.  Circulating Tumor Cell Clusters: United We Stand Divided We Fall.

Authors:  Samuel Amintas; Aurélie Bedel; François Moreau-Gaudry; Julian Boutin; Louis Buscail; Jean-Philippe Merlio; Véronique Vendrely; Sandrine Dabernat; Etienne Buscail
Journal:  Int J Mol Sci       Date:  2020-04-10       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.